Aakaar Medical Technologies IPO Date, Price, GMP, Details

The IPO opportunity of Aakaar Medical Technologies Limited gives investors the opportunity to invest into an expanding medical technology and healthcare equipment industry in India. Aakaar Medical Technologies Limited is a healthcare technology company that manufactures medical devices, healthcare solutions, and medical equipment in all segments of healthcare in India. Aakaar Medical Technologies Limited is based in Mumbai and is well located to take advantage of India’s increasing infrastructure and growing adoption and utilization of medical technology in India.

The issue price is ₹72 a share, and shares will list on BSE SME. The current Grey Market Premium (GMP) is ₹0 (0% premium), indicating the market sentiment is neutral with the current offering price.

IPO Dates for Aakaar Medical Technologies Limited

The Aakaar Medical Technologies Limited IPO is scheduled to open on June 20, 2025, and close on June 24, 2025. The allocation date is expected to be announced by June 25, 2025, with listing planned for June 27, 2025.

IPO Details Summary

About Aakaar Medical Technologies Limited IPO

Aakaar Medical Technologies Limited is a medical technology company which primarily engages in manufacturing healthcare equipment, medical devices and healthcare management solutions. Aakaar Medical provides services to a variety of sectors in healthcare including hospitals, clinics, diagnostic centers (labs), and other healthcare institutes, offering innovative medical technology solutions in line with modern healthcare delivery needs.

Aakaar Medical is located at Heritage Plaza, Andheri East, Mumbai, which is one of India's largest commercial and health care centers. The location provides potential medical practice partners easier access to qualified human resources, and proximity to potential health care partners with hospitals and healthcare facilities. Aakaar Medical has solid established record with healthcare solutions and been recognized as a trusted partner for healthcare facilities seeking next generation medical equipment and solutions to enhance patient care and efficiency of operations.

The IPO proceeds will assist Aakaar Medical enhance its manufacturing operations, invest in research and development, invest in technology and systems enablement, and expand its overall capacity and capabilities in the highly competitive medical technology space. Listing on the BSE SME (small and medium enterprises), demonstrates the growth stage capacity and long-term growth potential for Aakaar Medical.

The company's servicing and product structure includes manufacturing medical equipment, health tech, diagnostic equipment, and medical devices resulting in complete end-to-end healthcare technology solutions. As one of the fastest modernizing and digitizing sectors in India, the healthcare sector will create huge opportunities for Aakaar Medical as demand for innovative advanced medical technology based solutions grows.

Financial Performance of Aakaar Medical Technologies Limited

The company has demonstrated steady financial performance with consistent growth across key metrics:

Amount in ₹ Crores

Performance Analysis

Aakaar Medical Technologies Limited has shown consistent growth in the financials, with total assets increasing from ₹23.2 Cr to ₹51.9 Cr, total revenue increasing from ₹32.9 Cr to ₹61.8 Cr. Profit After Tax increased from ₹2.2 Cr to ₹6.0 Cr showing healthy margins and operating efficiencies. Net worth more than doubled to ₹23.2 Cr, indicating strong internal growth, and borrowings also increased to ₹22.7 Cr, due to the capital invested in the business.

IPO Share Reservation

The IPO share allocation follows standard SEBI guidelines for SME listings:

Sector Comparison

Latest reported period (Mar-25)

Know Before Investing

Risks

1. Competition : Intense competition from established medical technology companies and numerous SME players could limit pricing power and market share growth.

2. Regulatory Compliance : Medical device industry is highly regulated with stringent quality standards and regulatory approvals required, which can impact product development timelines.

3. Technology Obsolescence : Rapid advances in medical technology require continuous investment in R&D and equipment upgrades to remain competitive.

4. Client Concentration : Dependence on key healthcare institutions for significant revenue exposes the company to client loss risks.

5. Capital Intensity : Medical technology business requires substantial capital investments in manufacturing facilities and technology infrastructure.

6. Economic Sensitivity : Healthcare spending and capital expenditure by hospitals can be affected by economic downturns and healthcare policy changes.

7.Quality Risks : Medical device manufacturing requires strict quality control; any quality issues can lead to recalls and regulatory penalties.

8. SME Listing Risks : BSE SME listings typically have lower liquidity and higher volatility compared to main board listings.

Strengths

1. Consistent Revenue Growth : Revenue growth from ₹32.9 crores to ₹61.8 crores over three years demonstrates strong market acceptance and business expansion capability.

2. Improving Profitability : Profit After Tax growth from ₹2.2 crores to ₹6.0 crores shows operational efficiency improvements and better margins.

3. Growing Healthcare Market : Positioned in India's rapidly expanding healthcare sector with increasing demand for medical technology and equipment.

4. Strategic Location : Mumbai location provides access to major healthcare institutions, skilled workforce, and business opportunities.

5. Diversified Portfolio : Comprehensive medical technology solutions create multiple revenue streams and reduce dependency on single product lines.

6. Strong Asset Base : Total assets growth from ₹23.2 crores to ₹51.9 crores indicates substantial business scale and infrastructure development.

7. Established Market Presence : Growing reserves and surplus indicate reinvestment in business and financial stability.

8. Healthcare Digitalization Trend : Well-positioned to benefit from ongoing digitalization and modernization of healthcare infrastructure in India.

How to Apply for Aakaar Medical Technologies Limited IPO?

Step-by-step guide (when IPO opens):

→ Log in to your broker app (Zerodha, Angel One, Groww, etc.)

→ Navigate to the IPO section and select Aakaar Medical Technologies Limited IPO

→ Click "Apply"

→ Enter:

• Lot size (minimum 1,600 shares)

• Bid price (₹72 or select Cut-Off)

• Your UPI ID

→ Submit the application

→ Approve the UPI mandate in your UPI app (PhonePe, GPay, etc.)

⏰ Important: Mandate must be approved before 5 PM on the same day or before IPO closes.

How to Check Aakaar Medical IPO Allotment Status?

You can check allotment status through BSE and the registrar portal once the IPO opens.

Check On BSE

1. Visit the BSE official website.

2. Navigate to the IPO Allotment Section.

3. Select Aakaar Medical Technologies Limited IPO.

4. Enter PAN number or application number.

5. Submit details to get allotment status.

Check On the Registrar Portal

1. Visit Bigshare Services Pvt Ltd's website.

2. Select IPO allotment status.

3. Choose Aakaar Medical Technologies Limited IPO.

4. Enter PAN or application number.

5. Submit to check status.

Company Address

Name : Aakaar Medical Technologies Limited
Address : 801, Heritage Plaza, Telli Galli Cross Road, Andheri (East), Mumbai, Maharashtra, 400069
Phone : +91 84528 44024
Email : companysecretary@aakaarmedical.in
Website : https://aakaarmedical.in

IPO Registrar

Name : Bigshare Services Pvt Ltd
Address : 1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri(E), Mumbai - 400 059
Phone : +91-22-62638200
Email : ipo@bigshareonline.com
Website : https://ipo.bigshareonline.com/IPO_Status.html

Conclusion

Investors may find the Aakaar Medical Technologies Limited IPO to be an exciting opportunity in India's expanding medical technology space. The company has demonstrated stable financial performance, including steadily increasing revenues from ₹32.9 crores to ₹61.8 crores and improving working capital and profitability. The healthcare technology space is a very important growth segment, driven by India's increasing healthcare infrastructure and initiatives around digitalization.

The company's diverse medical technology portfolio and strategic location in Mumbai may provide competitive advantages in serving the healthcare market in India. However, as an initial public offering participant, it’s important for investors to understand the significant amount of capital required to grow amid its current increasing debt, plans for further debt, and the competitive dynamics that characterize the healthcare technology sector.

Based on a price of ₹72 per share, the valuation seems reasonable for a company in a growing sector with reasonable growth fundamentals. If you are considering an investment, I would encourage careful evaluation of the company's competitive positioning and future growth prospects.

At the same time, the company presents with only moderate profit margins, and an increasing amount of debt; thus it is critical that the company put in place its financial management as it scales. Potential regulatory and quality requirements associated with the health sector would also be a continued challenge (compliance).

Disclaimer : This analysis is for educational purposes only and should not be considered as financial advice. Please consult with your financial advisor before making any investment decisions. Medical technology sector investments carry market risks and are subject to regulatory changes.

FAQs